Evidence map›Paper›PMID 37352255›Full record

ArticlePloS one2023

Perceived threat and fear responses to e-cigarette warning label messages: Results from 16 focus groups with U.S. youth and adults.

Rosemary J Avery, Motasem Kalaji, Jeff Niederdeppe, Alan Mathios, Michael Dorf, Sahara Byrne, Amelia Greiner Safi

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. The Role of e-Cigarette Packaging as a Health Communications Tool: A Focus Group Study With Adolescents and Adults in England and Scotland.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Article
  7. Article
  8. A Content Analysis of Nicotine Descriptors on the Front of Vape Packaging in the United Kingdom.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Rosemary J AveryJeb E. Brooks School of Public Policy, Cornell University, Ithaca, NY, United States of America.ORCID 0000-0002-8012-8463
Motasem KalajiDepartment of Communication Studies, California State University, Northridge, Los Angeles, CA, United States of America.
Jeff NiederdeppeJeb E. Brooks School of Public Policy, Cornell University, Ithaca, NY, United States of America.
Alan MathiosJeb E. Brooks School of Public Policy, Cornell University, Ithaca, NY, United States of America.
Michael DorfLaw School, Cornell University, Ithaca, NY, United States of America.
Sahara ByrneDepartment of Communication, Cornell University, Ithaca, NY, United States of America.
Amelia Greiner SafiDepartment of Communication, Cornell University, Ithaca, NY, United States of America.ORCID 0000-0001-6742-0219
Cornell University · USCalifornia State University, Northridge · US

Funding

The E-Cigarette Population Paradox: Testing Effects of Youth-Targeted Population Warnings for E-Cigarettes among Two Key PopulationsR01CA246605 · NCI · CORNELL UNIVERSITY · PI BYRNE, SAHARA ELIZABETH, NIEDERDEPPE, JEFFREY D · 2019 to 2021
$1.3M
NCI NIH HHS R01 CA246605
6 · The paper itself

Abstract

aimsA warning on e-cigarette packaging is one way the U.S. government can inform the public of known harms of e-cigarette use. Currently, the only required warning on these products is: "WARNING: This product contains nicotine. Nicotine is an addictive chemical." This exploratory study aims to inform potential future investigations and FDA decisions regarding alternative warnings that may generate fear in addition to being intentionally informational.

methodData were obtained from responses by 16 online focus groups with adult (N = 47, age range = 18-64) and youth (N = 32, age range 14-16) participants with various smoking and vaping experiences. We showed each focus group a set of hypothetical e-cigarette warning labels to determine how they respond to currently existing public statements that communicate information on the toxicity of ingredients in e-cigarettes, potential health risks, addiction to nicotine, and the uncertainty of the science regarding health effects of using these products. The focus group interviews were audio recorded and transcribed. Transcripts were subjected to a multiphase coding process to identify common response themes. Codes derived from the Extended Parallel Processing Model were then applied to understand impact of potentially fear-inducing language by warning category and age group.

resultsFor adults, all warnings-except those about addiction-gave rise to spontaneous danger control (intended) responses, such as quit intentions. Warnings highlighting cognitive and uncertain effects may be particularly promising for adult consumers of tobacco products because both gengerated danger control and response efficacy without evidence of fear control. However, responses also suggest that warnings risk discouraging some adults who use combustible cigarettes from transitioning to e-cigarettes for harm reduction. For youth, while evidence of response efficacy and danger control emerged among youth exposed to messages in all warning categories but one-addiction-unproductive reactions indicative of fear control were also prevalent among youth respondent across most warning types. On average, youth were more skeptical than adults about the harms of using e-cigarettes. POLICY IMPLICATIONS: Implications of study findings for the development of future effective e-cigarette warning messages are explored.

Indexed as

Behavior, AddictiveElectronic Nicotine Delivery SystemsTobacco ProductsAdolescentAdultFearFocus GroupsHumansMiddle AgedNicotineProduct LabelingYoung AdultNicotine

Identifiers

PMID37352255
PMCPMC10289367
OpenAlexW4381839294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.